TermID Term Enrichment logP Genes in Term Target Genes in Term Fraction of Targets in Term Total Target Genes Total Genes Entrez Gene IDs Gene Symbols WP3679 Cell-type Dependent Selectivity of CCK2R Signaling 0.00135998198870559 -6.60028382292071 13 2 0.0869565217391304 23 5310 6263,23236 RYR3,PLCB1 WP673 ErbB Signaling Pathway 0.0224046229923579 -3.7984879578279 54 2 0.0869565217391304 23 5310 10718,2066 NRG3,ERBB4 WP2059 Alzheimers Disease 0.0249746713900794 -3.68989311208846 148 3 0.130434782608696 23 5310 23236,6263,348 PLCB1,RYR3,APOE WP536 Calcium Regulation in the Cardiac Cell 0.0263126192208157 -3.63770663659244 151 3 0.130434782608696 23 5310 108,6263,9628 ADCY2,RYR3,RGS6 WP289 Myometrial Relaxation and Contraction Pathways 0.0295840828815346 -3.52051880277509 158 3 0.130434782608696 23 5310 108,6263,9628 ADCY2,RYR3,RGS6 WP2032 Human Thyroid Stimulating Hormone (TSH) signaling pathway 0.034386023390495 -3.37010509395162 68 2 0.0869565217391304 23 5310 23236,108 PLCB1,ADCY2 WP3297 EV release from cardiac cells and their functional effects 0.0383428137723569 -3.26118815406389 9 1 0.0434782608695652 23 5310 2066 ERBB4 WP3601 Composition of Lipid Particles 0.04251525581794 -3.15789230704053 10 1 0.0434782608695652 23 5310 348 APOE WP3301 MFAP5-mediated ovarian cancer cell motility and invasiveness 0.0508082498350287 -2.97969653925554 12 1 0.0434782608695652 23 5310 6263 RYR3 WP3853 ERK Pathway in Huntington's Disease 0.0590325133754942 -2.8296669127011 14 1 0.0434782608695652 23 5310 4915 NTRK2 WP2064 Neural Crest Differentiation 0.0711837032884833 -2.6424913731604 102 2 0.0869565217391304 23 5310 6660,2670 SOX5,GFAP WP3678 Amplification and Expansion of Oncogenic Pathways as Metastatic Traits 0.0712412277794019 -2.64168358629872 17 1 0.0434782608695652 23 5310 3371 TNC WP185 Integrin-mediated Cell Adhesion 0.0724057821396804 -2.62546911897167 103 2 0.0869565217391304 23 5310 10580,5602 SORBS1,MAPK10 WP3859 TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition 0.0752770206688784 -2.58658036115027 18 1 0.0434782608695652 23 5310 3371 TNC WP399 Wnt Signaling Pathway and Pluripotency 0.0761137348061893 -2.57552654674414 106 2 0.0869565217391304 23 5310 5602,5521 MAPK10,PPP2R2B WP384 Apoptosis Modulation by HSP70 0.0792960358843376 -2.53456714043902 19 1 0.0434782608695652 23 5310 5602 MAPK10 WP1602 Nicotine Activity on Dopaminergic Neurons 0.087283999410613 -2.43858811574578 21 1 0.0434782608695652 23 5310 108 ADCY2 WP1424 Globo Sphingolipid Metabolism 0.0912530801474453 -2.39411853204873 22 1 0.0434782608695652 23 5310 10690 FUT9 WP2431 Spinal Cord Injury 0.0928601628832387 -2.37666054231869 119 2 0.0869565217391304 23 5310 2670,5803 GFAP,PTPRZ1 WP26 Signal Transduction of S1P Receptor 0.106964929572013 -2.23525425925483 26 1 0.0434782608695652 23 5310 23236 PLCB1 WP422 MAPK Cascade 0.118577942088021 -2.13218479548312 29 1 0.0434782608695652 23 5310 5602 MAPK10 WP2643 Nanoparticle-mediated activation of receptor signaling 0.118577942088021 -2.13218479548312 29 1 0.0434782608695652 23 5310 5602 MAPK10 WP408 Oxidative Stress 0.126239548802094 -2.06957399601886 31 1 0.0434782608695652 23 5310 5602 MAPK10 WP2858 Ectoderm Differentiation 0.126255352529724 -2.06944881545033 143 2 0.0869565217391304 23 5310 1496,1501 CTNNA2,CTNND2 WP2380 Brain-Derived Neurotrophic Factor (BDNF) signaling pathway 0.127706124059559 -2.05802356047991 144 2 0.0869565217391304 23 5310 5602,4915 MAPK10,NTRK2 WP3893 Development and heterogeneity of the ILC family 0.130046423280616 -2.03986379011377 32 1 0.0434782608695652 23 5310 6095 RORA WP3676 BDNF-TrkB Signaling 0.133837429773575 -2.011129426212 33 1 0.0434782608695652 23 5310 4915 NTRK2 WP2197 Endothelin Pathways 0.133837429773575 -2.011129426212 33 1 0.0434782608695652 23 5310 23236 PLCB1 WP430 Statin Pathway 0.133837429773575 -2.011129426212 33 1 0.0434782608695652 23 5310 348 APOE WP500 Glycogen Metabolism 0.145115871598686 -1.93022274120984 36 1 0.0434782608695652 23 5310 5521 PPP2R2B WP3298 Melatonin metabolism and effects 0.145115871598686 -1.93022274120984 36 1 0.0434782608695652 23 5310 348 APOE WP2447 Amyotrophic lateral sclerosis (ALS) 0.152556644209009 -1.88021931446435 38 1 0.0434782608695652 23 5310 6506 SLC1A2 WP481 Insulin Signaling 0.152965621118818 -1.87754208140803 161 2 0.0869565217391304 23 5310 10580,5602 SORBS1,MAPK10 WP706 Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 0.154483348729136 -1.86766896366845 162 2 0.0869565217391304 23 5310 4915,6095 NTRK2,RORA WP170 Nuclear Receptors 0.156253760521123 -1.85627392332005 39 1 0.0434782608695652 23 5310 6095 RORA WP524 G13 Signaling Pathway 0.159935445875219 -1.8329850084414 40 1 0.0434782608695652 23 5310 5602 MAPK10 WP2637 Structural Pathway of Interleukin 1 (IL-1) 0.195917009791701 -1.63006412884904 50 1 0.0434782608695652 23 5310 5602 MAPK10 WP1533 Vitamin B12 Metabolism 0.206420800352687 -1.57783847354983 53 1 0.0434782608695652 23 5310 348 APOE WP2864 Apoptosis-related network due to altered Notch3 in ovarian cancer 0.209892803698581 -1.56115833717119 54 1 0.0434782608695652 23 5310 348 APOE WP2795 Cardiac Hypertrophic Response 0.220221849385803 -1.51311983443075 57 1 0.0434782608695652 23 5310 5592 PRKG1 WP3594 Circadian rythm related genes 0.225348346353706 -1.49010786799663 207 2 0.0869565217391304 23 5310 6095,5602 RORA,MAPK10 WP558 Complement and Coagulation Cascades 0.23042166119469 -1.46784433897764 60 1 0.0434782608695652 23 5310 1191 CLU WP3865 RIG-I-like Receptor Signaling 0.233793147252453 -1.45331854067119 61 1 0.0434782608695652 23 5310 5602 MAPK10 WP474 Endochondral Ossification 0.247138347607569 -1.39780698738668 65 1 0.0434782608695652 23 5310 6660 SOX5 WP3651 Pathways Affected in Adenoid Cystic Carcinoma 0.250439742841508 -1.38453693493231 66 1 0.0434782608695652 23 5310 9863 MAGI2 WP1403 AMP-activated Protein Kinase (AMPK) Signaling 0.257001038049964 -1.35867515499016 68 1 0.0434782608695652 23 5310 23236 PLCB1 WP3680 Association Between Physico-Chemical Features and Toxicity Associated Pathways 0.257001038049964 -1.35867515499016 68 1 0.0434782608695652 23 5310 2066 ERBB4 WP428 Wnt Signaling Pathway 0.263507375001606 -1.3336739227715 70 1 0.0434782608695652 23 5310 5602 MAPK10 WP2118 Arrhythmogenic Right Ventricular Cardiomyopathy 0.28270101547935 -1.26336542221494 76 1 0.0434782608695652 23 5310 1496 CTNNA2 WP254 Apoptosis 0.313631626071599 -1.15953614714815 86 1 0.0434782608695652 23 5310 5602 MAPK10 WP35 G Protein Signaling Pathways 0.34037488289895 -1.07770767202367 95 1 0.0434782608695652 23 5310 108 ADCY2 WP1544 MicroRNAs in cardiomyocyte hypertrophy 0.360483096824311 -1.0203102114998 102 1 0.0434782608695652 23 5310 5592 PRKG1 WP75 Toll-like Receptor Signaling Pathway 0.363307384224024 -1.01250601454446 103 1 0.0434782608695652 23 5310 5602 MAPK10 WP710 DNA Damage Response (only ATM dependent) 0.393597476487659 -0.932426525187247 114 1 0.0434782608695652 23 5310 5602 MAPK10 WP236 Adipogenesis 0.437714267158829 -0.826188939568678 131 1 0.0434782608695652 23 5310 6095 RORA WP3915 Angiopoietin Like Protein 8 Regulatory Pathway 0.4402113847168 -0.82050024762357 132 1 0.0434782608695652 23 5310 5602 MAPK10 WP366 TGF-beta Signaling Pathway 0.442697892670475 -0.814867699430489 133 1 0.0434782608695652 23 5310 3371 TNC WP1449 Regulation of toll-like receptor signaling pathway 0.471723938245167 -0.751361341102842 145 1 0.0434782608695652 23 5310 5602 MAPK10 WP382 MAPK Signaling Pathway 0.527620108267351 -0.639378746152302 170 1 0.0434782608695652 23 5310 5602 MAPK10 WP306 Focal Adhesion 0.577832736740607 -0.54847083499076 195 1 0.0434782608695652 23 5310 3371 TNC WP2526 PDGF Pathway 0.999999999995251 -4.74869777670421e-12 38 0 0 23 5310 WP2029 Cell Differentiation - Index 0.999999999995251 -4.74869777670421e-12 38 0 0 23 5310 WP383 Striated Muscle Contraction 0.999999999995251 -4.74869777670421e-12 38 0 0 23 5310 WP2359 Parkin-Ubiquitin Proteasomal System pathway 0.999999999995855 -4.14485827944395e-12 70 0 0 23 5310 WP136 Phase I biotransformations, non P450 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP3407 FTO Obesity Variant Mechanism 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP3635 Insulin signalling in human adipocytes (diabetic condition) 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP3634 Insulin signalling in human adipocytes (normal condition) 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP237 Glucocorticoid & Mineralcorticoid Metabolism 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP2276 Glial Cell Differentiation 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP2338 miRNA Biogenesis 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP3655 Hypothetical Craniofacial Development Pathway 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP1589 Folate-Alcohol and Cancer Pathway 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP1604 Codeine and Morphine Metabolism 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP2485 NAD Biosynthesis II (from tryptophan) 0.999999999995962 -4.03778810030353e-12 8 0 0 23 5310 WP2012 miRs in Muscle Cell Differentiation 0.999999999997094 -2.90629076236783e-12 36 0 0 23 5310 WP138 Androgen receptor signaling pathway 0.999999999998444 -1.55604489699114e-12 90 0 0 23 5310 WP477 Cytoplasmic Ribosomal Proteins 0.999999999998444 -1.55604489699114e-12 90 0 0 23 5310 WP3585 Cytosine methylation 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP3593 miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP561 Heme Biosynthesis 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP3875 ATR Signaling 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP3674 Tgif disruption of Shh signaling 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP288 NLR Proteins 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP531 Mismatch repair 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP3300 Dual hijack model of Vif in HIV infection 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP696 Benzo(a)pyrene metabolism 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP2942 DDX1 as a regulatory component of the Drosha microprocessor 0.999999999999247 -7.5257012590757e-13 9 0 0 23 5310 WP395 IL-4 Signaling Pathway 0.999999999999625 -3.75432870016469e-13 55 0 0 23 5310 WP585 Interferon type I signaling pathways 0.999999999999625 -3.75432870016469e-13 55 0 0 23 5310 WP2018 RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway 0.999999999999625 -3.75432870016469e-13 55 0 0 23 5310 WP2272 Pathogenic Escherichia coli infection 0.999999999999625 -3.75432870016469e-13 55 0 0 23 5310 WP325 Triacylglyceride Synthesis 0.999999999999715 -2.84969973751277e-13 26 0 0 23 5310 WP530 Cytokines and Inflammatory Response 0.999999999999715 -2.84969973751277e-13 26 0 0 23 5310 WP698 Glucuronidation 0.999999999999715 -2.84969973751277e-13 26 0 0 23 5310 WP2878 PPAR Alpha Pathway 0.999999999999715 -2.84969973751277e-13 26 0 0 23 5310 WP581 EPO Receptor Signaling 0.999999999999715 -2.84969973751277e-13 26 0 0 23 5310 WP497 Urea cycle and metabolism of amino groups 0.999999999999754 -2.46176058446469e-13 20 0 0 23 5310 WP732 Serotonin Receptor 2 and ELK-SRF/GATA4 signaling 0.999999999999754 -2.46176058446469e-13 20 0 0 23 5310 WP516 Hypertrophy Model 0.999999999999754 -2.46176058446469e-13 20 0 0 23 5310 WP391 Mitochondrial Gene Expression 0.999999999999754 -2.46176058446469e-13 20 0 0 23 5310 WP1742 TP53 Network 0.999999999999754 -2.46176058446469e-13 20 0 0 23 5310 WP1422 Sphingolipid Metabolism 0.999999999999754 -2.46176058446469e-13 20 0 0 23 5310 WP2267 Synaptic Vesicle Pathway 1.0000000000008 8.00484512067865e-13 52 0 0 23 5310 WP2369 Histone Modifications 1.00000000000112 1.11799756758431e-12 69 0 0 23 5310 WP707 DNA Damage Response 1.00000000000112 1.11799756758431e-12 69 0 0 23 5310 WP176 Folate Metabolism 1.00000000000112 1.11799756758431e-12 69 0 0 23 5310 WP195 IL-1 signaling pathway 1.00000000000123 1.22515646743587e-12 57 0 0 23 5310 WP2361 Gastric Cancer Network 1 1.00000000000127 1.27479306750969e-12 28 0 0 23 5310 WP2249 Metastatic brain tumor 1.00000000000127 1.27479306750969e-12 28 0 0 23 5310 WP1545 miRNAs involved in DNA damage response 1.00000000000157 1.57180388100844e-12 50 0 0 23 5310 WP734 Serotonin Receptor 4/6/7 and NR3C Signaling 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP3877 Simplified Depiction of MYD88 Distinct Input-Output Pathway 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP2011 SREBF and miR33 in cholesterol and lipid homeostasis 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP697 Estrogen metabolism 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP247 Small Ligand GPCRs 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP2879 Farnesoid X Receptor Pathway 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP22 IL-9 Signaling Pathway 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP1992 TarBasePathway 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP404 Nucleotide Metabolism 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP3287 Overview of nanoparticle effects 1.00000000000217 2.16524701137825e-12 19 0 0 23 5310 WP2857 Mesodermal Commitment Pathway 1.00000000000222 2.21846838866637e-12 155 0 0 23 5310 WP2113 Type III interferon signaling 1.00000000000232 2.3170940169582e-12 10 0 0 23 5310 WP2333 Trans-sulfuration pathway 1.00000000000232 2.3170940169582e-12 10 0 0 23 5310 WP1531 Vitamin D Metabolism 1.00000000000232 2.3170940169582e-12 10 0 0 23 5310 WP3656 Interleukin-1 Induced Activation of NF-kappa-B 1.00000000000232 2.3170940169582e-12 10 0 0 23 5310 WP2874 Liver X Receptor Pathway 1.00000000000232 2.3170940169582e-12 10 0 0 23 5310 WP496 Steroid Biosynthesis 1.00000000000232 2.3170940169582e-12 10 0 0 23 5310 WP704 Methylation Pathways 1.00000000000232 2.3170940169582e-12 10 0 0 23 5310 WP2332 Interleukin-11 Signaling Pathway 1.00000000000279 2.79209524197596e-12 44 0 0 23 5310 WP314 Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation 1.00000000000279 2.79209524197596e-12 44 0 0 23 5310 WP716 Vitamin A and Carotenoid Metabolism 1.00000000000279 2.79209524197596e-12 44 0 0 23 5310 WP2035 Follicle Stimulating Hormone (FSH) signaling pathway 1.00000000000351 3.50538045576403e-12 27 0 0 23 5310 WP3845 Canonical and Non-canonical Notch signaling 1.00000000000351 3.50538045576403e-12 27 0 0 23 5310 WP183 Proteasome Degradation 1.00000000000358 3.5831999149605e-12 66 0 0 23 5310 WP2324 AGE/RAGE pathway 1.00000000000358 3.5831999149605e-12 66 0 0 23 5310 WP2374 Oncostatin M Signaling Pathway 1.00000000000358 3.5831999149605e-12 66 0 0 23 5310 WP3286 Copper homeostasis 1.00000000000382 3.8154593330429e-12 54 0 0 23 5310 WP623 Oxidative phosphorylation 1.00000000000382 3.8154593330429e-12 54 0 0 23 5310 WP2328 Allograft Rejection 1.00000000000394 3.94090707832513e-12 80 0 0 23 5310 WP2436 Dopamine metabolism 1.00000000000406 4.05841504221781e-12 14 0 0 23 5310 WP322 Osteoblast Signaling 1.00000000000406 4.05841504221781e-12 14 0 0 23 5310 WP229 Irinotecan Pathway 1.00000000000406 4.05841504221781e-12 14 0 0 23 5310 WP2646 Lidocaine metabolism 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP1311 Folic Acid Network 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP1438 Influenza A virus infection 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP1273 Folic Acid Network 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP2901 Gonadotropin-releasing hormone (GnRH) signaling 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP2366 Butyrate-induced histone acetylation 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP2816 Felbamate Metabolism 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP2943 Hypoxia-mediated EMT and Stemness 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP2866 mir34a and TGIF2 in osteoclastogenesis 1.00000000000435 4.35348743952355e-12 2 0 0 23 5310 WP107 Translation Factors 1.00000000000435 4.35504639380091e-12 53 0 0 23 5310 WP2406 Cardiac Progenitor Differentiation 1.00000000000435 4.35504639380091e-12 53 0 0 23 5310 WP363 Wnt Signaling Pathway Netpath 1.00000000000435 4.35504639380091e-12 53 0 0 23 5310 WP2037 Prolactin Signaling Pathway 1.00000000000449 4.4851452762915e-12 76 0 0 23 5310 WP2034 Leptin signaling pathway 1.00000000000449 4.4851452762915e-12 76 0 0 23 5310 WP2036 TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway 1.00000000000452 4.52174573687387e-12 42 0 0 23 5310 WP2636 Common Pathways Underlying Drug Addiction 1.00000000000452 4.52174573687387e-12 42 0 0 23 5310 WP466 DNA Replication 1.00000000000452 4.52174573687387e-12 42 0 0 23 5310 WP49 IL-2 Signaling Pathway 1.00000000000452 4.52174573687387e-12 42 0 0 23 5310 WP405 Eukaryotic Transcription Initiation 1.00000000000452 4.52174573687387e-12 42 0 0 23 5310 WP1991 SRF and miRs in Smooth Muscle Differentiation and Proliferation 1.00000000000468 4.67688132278463e-12 13 0 0 23 5310 WP3892 Development of pulmonary dendritic cells and macrophage subsets 1.00000000000468 4.67688132278463e-12 13 0 0 23 5310 WP3871 Valproic acid pathway 1.00000000000468 4.67688132278463e-12 13 0 0 23 5310 WP186 Homologous recombination 1.00000000000468 4.67688132278463e-12 13 0 0 23 5310 WP3876 BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation 1.00000000000468 4.67688132278463e-12 13 0 0 23 5310 WP1434 Osteopontin Signaling 1.00000000000468 4.67688132278463e-12 13 0 0 23 5310 WP2881 Estrogen Receptor Pathway 1.00000000000468 4.67688132278463e-12 13 0 0 23 5310 WP1423 Ganglio Sphingolipid Metabolism 1.00000000000468 4.67688132278463e-12 13 0 0 23 5310 WP262 EBV LMP1 signaling 1.00000000000515 5.14911591812585e-12 24 0 0 23 5310 WP2509 Nanoparticle triggered autophagic cell death 1.00000000000515 5.14911591812585e-12 24 0 0 23 5310 WP334 GPCRs, Class B Secretin-like 1.00000000000515 5.14911591812585e-12 24 0 0 23 5310 WP3658 Wnt/beta-catenin Signaling Pathway in Leukemia 1.00000000000515 5.14911591812585e-12 24 0 0 23 5310 WP1539 Angiogenesis 1.00000000000515 5.14911591812585e-12 24 0 0 23 5310 WP117 GPCRs, Other 1.00000000000524 5.23669061081625e-12 95 0 0 23 5310 WP2371 Parkinsons Disease Pathway 1.00000000000587 5.87114746195219e-12 83 0 0 23 5310 WP2261 Signaling Pathways in Glioblastoma 1.00000000000587 5.87114746195219e-12 83 0 0 23 5310 WP2289 Drug Induction of Bile Acid Pathway 1.00000000000597 5.97222549783533e-12 17 0 0 23 5310 WP554 ACE Inhibitor Pathway 1.00000000000597 5.97222549783533e-12 17 0 0 23 5310 WP368 Mitochondrial LC-Fatty Acid Beta-Oxidation 1.00000000000597 5.97222549783533e-12 17 0 0 23 5310 WP78 TCA Cycle 1.00000000000597 5.97222549783533e-12 17 0 0 23 5310 WP2916 Interactome of polycomb repressive complex 2 (PRC2) 1.00000000000597 5.97222549783533e-12 17 0 0 23 5310 WP3874 Canonical and Non-Canonical TGF-B signaling 1.00000000000597 5.97222549783533e-12 17 0 0 23 5310 WP2112 IL17 signaling pathway 1.00000000000636 6.35820385588729e-12 31 0 0 23 5310 WP3850 Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling 1.00000000000636 6.35820385588729e-12 31 0 0 23 5310 WP3527 Preimplantation Embryo 1.00000000000691 6.90755465255214e-12 60 0 0 23 5310 WP304 Kit receptor signaling pathway 1.00000000000691 6.90755465255214e-12 60 0 0 23 5310 WP692 Sulfation Biotransformation Reaction 1.00000000000706 7.06085613435746e-12 18 0 0 23 5310 WP3664 Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds 1.00000000000706 7.06085613435746e-12 18 0 0 23 5310 WP3413 NOTCH1 regulation of human endothelial cell calcification 1.00000000000706 7.06085613435746e-12 18 0 0 23 5310 WP3879 4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression 1.00000000000706 7.06085613435746e-12 18 0 0 23 5310 WP2868 TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer 1.00000000000712 7.11865300280212e-12 5 0 0 23 5310 WP3596 miR-517 relationship with ARCN1 and USP1 1.00000000000712 7.11865300280212e-12 5 0 0 23 5310 WP311 Synthesis and Degradation of Ketone Bodies 1.00000000000712 7.11865300280212e-12 5 0 0 23 5310 WP688 Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) 1.00000000000712 7.11865300280212e-12 5 0 0 23 5310 WP2542 Sulindac Metabolic Pathway 1.00000000000712 7.11865300280212e-12 5 0 0 23 5310 WP2597 Secretion of Hydrochloric Acid in Parietal Cells 1.00000000000712 7.11865300280212e-12 5 0 0 23 5310 WP3657 Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP3599 Transcription factor regulation in adipogenesis 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP357 Fatty Acid Biosynthesis 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP3645 NAD+ biosynthetic pathways 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP100 Glutathione metabolism 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP1584 Type II diabetes mellitus 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP167 Eicosanoid Synthesis 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP545 Complement Activation 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP272 Blood Clotting Cascade 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP3872 Regulation of Apoptosis by Parathyroid Hormone-related Protein 1.00000000000744 7.43634897548052e-12 22 0 0 23 5310 WP231 TNF alpha Signaling Pathway 1.00000000000746 7.4638802682746e-12 94 0 0 23 5310 WP1772 Apoptosis Modulation and Signaling 1.00000000000746 7.4638802682746e-12 94 0 0 23 5310 WP1559 TFs Regulate miRNAs related to cardiac hypertrophy 1.00000000000747 7.47335388570368e-12 12 0 0 23 5310 WP2007 Iron metabolism in placenta 1.00000000000747 7.47335388570368e-12 12 0 0 23 5310 WP1425 Bone Morphogenic Protein (BMP) Signalling and Regulation 1.00000000000747 7.47335388570368e-12 12 0 0 23 5310 WP3849 MAPK and NFkB Signalling Pathways Inhibited by Yersinia YopJ 1.00000000000747 7.47335388570368e-12 12 0 0 23 5310 WP3672 LncRNA-mediated mechanisms of therapeutic resistance 1.00000000000747 7.47335388570368e-12 12 0 0 23 5310 WP2290 RalA downstream regulated genes 1.00000000000747 7.47335388570368e-12 12 0 0 23 5310 WP106 Alanine and aspartate metabolism 1.00000000000747 7.47335388570368e-12 12 0 0 23 5310 WP2846 Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation 1.00000000000754 7.53604629893352e-12 3 0 0 23 5310 WP3408 Evolocumab Mechanism 1.00000000000754 7.53604629893352e-12 3 0 0 23 5310 WP23 B Cell Receptor Signaling Pathway 1.00000000000757 7.57044251674038e-12 98 0 0 23 5310 WP2377 Integrated Pancreatic Cancer Pathway 1.00000000000779 7.79375089513348e-12 197 0 0 23 5310 WP3863 T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection 1.00000000000788 7.88091372674154e-12 62 0 0 23 5310 WP3584 MECP2 and Associated Rett Syndrome 1.00000000000788 7.88091372674154e-12 62 0 0 23 5310 WP61 Notch Signaling Pathway 1.00000000000788 7.88091372674154e-12 62 0 0 23 5310 WP455 GPCRs, Class A Rhodopsin-like 1.0000000000079 7.9036906103717e-12 259 0 0 23 5310 WP2853 Endoderm Differentiation 1.00000000000793 7.92606721071482e-12 145 0 0 23 5310 WP2363 Gastric Cancer Network 2 1.00000000000794 7.94337524919561e-12 33 0 0 23 5310 WP58 Monoamine GPCRs 1.00000000000794 7.94337524919561e-12 33 0 0 23 5310 WP453 Inflammatory Response Pathway 1.00000000000794 7.94337524919561e-12 33 0 0 23 5310 WP2583 T-Cell Receptor and Co-stimulatory Signaling 1.00000000000801 8.0062152831963e-12 29 0 0 23 5310 WP3613 Photodynamic therapy-induced unfolded protein response 1.00000000000801 8.0062152831963e-12 29 0 0 23 5310 WP2516 ATM Signaling Pathway 1.00000000000806 8.05988963838948e-12 40 0 0 23 5310 WP127 IL-5 Signaling Pathway 1.00000000000806 8.05988963838948e-12 40 0 0 23 5310 WP702 Metapathway biotransformation 1.00000000000819 8.19000075439754e-12 177 0 0 23 5310 WP1310 Selenium Micronutrient Network 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP3595 mir-124 predicted interactions with cell cycle and differentiation 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP2805 RNA interference 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP678 Arachidonate Epoxygenase / Epoxide Hydrolase 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP1272 Selenium Micronutrient Network 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP134 Pentose Phosphate Pathway 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP3924 Hfe effect on hepcidin production 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP2596 Gastric acid production 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP1995 Effects of Nitric Oxide 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP699 Aflatoxin B1 metabolism 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP528 Acetylcholine Synthesis 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP438 Non-homologous end joining 1.00000000000886 8.86418818698943e-12 7 0 0 23 5310 WP43 Oxidation by Cytochrome P450 1.00000000000895 8.94540089616001e-12 63 0 0 23 5310 WP3624 Lung fibrosis 1.00000000000895 8.94540089616001e-12 63 0 0 23 5310 WP3646 Hepatitis C and Hepatocellular Carcinoma 1.00000000000906 9.05825764563248e-12 51 0 0 23 5310 WP3611 Photodynamic therapy-induced AP-1 survival signaling. 1.00000000000906 9.05825764563248e-12 51 0 0 23 5310 WP712 Estrogen signaling pathway 1.00000000000916 9.16094880142452e-12 23 0 0 23 5310 WP3612 Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling 1.00000000000916 9.16094880142452e-12 23 0 0 23 5310 WP3617 Photodynamic therapy-induced NF-kB survival signaling 1.00000000000918 9.17591793429264e-12 35 0 0 23 5310 WP299 Nuclear Receptors in Lipid Metabolism and Toxicity 1.00000000000918 9.17591793429264e-12 35 0 0 23 5310 WP244 Alpha 6 Beta 4 signaling pathway 1.00000000000918 9.17591793429264e-12 35 0 0 23 5310 WP12 Osteoclast Signaling 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP47 Hedgehog Signaling Pathway 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP2453 TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP501 GPCRs, Class C Metabotropic glutamate, pheromone 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP550 Biogenic Amine Synthesis 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP53 ID signaling pathway 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP2291 Deregulation of Rab and Rab Effector Genes in Bladder Cancer 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP3644 NAD+ metabolism 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP1946 Cori Cycle 1.00000000000924 9.2400570250452e-12 16 0 0 23 5310 WP179 Cell Cycle 1.00000000000934 9.33986806791462e-12 105 0 0 23 5310 WP1433 Nucleotide-binding Oligomerization Domain (NOD) pathway 1.00000000000972 9.7217801840354e-12 41 0 0 23 5310 WP34 Ovarian Infertility Genes 1.00000000001031 1.03111201753353e-11 32 0 0 23 5310 WP727 Monoamine Transport 1.00000000001031 1.03111201753353e-11 32 0 0 23 5310 WP2828 Bladder Cancer 1.00000000001031 1.03111201753353e-11 32 0 0 23 5310 WP2525 Trans-sulfuration and one carbon metabolism 1.00000000001031 1.03111201753353e-11 32 0 0 23 5310 WP3858 Toll-like Receptor Signaling 1.00000000001031 1.03111201753353e-11 32 0 0 23 5310 WP2875 Constitutive Androstane Receptor Pathway 1.00000000001031 1.03111201753353e-11 32 0 0 23 5310 WP400 p38 MAPK Signaling Pathway 1.00000000001035 1.03542864748929e-11 34 0 0 23 5310 WP1601 Fluoropyrimidine Activity 1.00000000001035 1.03542864748929e-11 34 0 0 23 5310 WP143 Fatty Acid Beta Oxidation 1.00000000001035 1.03542864748929e-11 34 0 0 23 5310 WP313 Signaling of Hepatocyte Growth Factor Receptor 1.00000000001035 1.03542864748929e-11 34 0 0 23 5310 WP364 IL-6 signaling pathway 1.00000000001037 1.03672677701691e-11 43 0 0 23 5310 WP2911 miRNA targets in ECM and membrane receptors 1.00000000001037 1.03672677701691e-11 43 0 0 23 5310 WP2870 Extracellular vesicle-mediated signaling in recipient cells 1.00000000001054 1.05447281869397e-11 30 0 0 23 5310 WP3851 TLR4 Signaling and Tolerance 1.00000000001054 1.05447281869397e-11 30 0 0 23 5310 WP129 Matrix Metalloproteinases 1.00000000001054 1.05447281869397e-11 30 0 0 23 5310 WP241 One Carbon Metabolism 1.00000000001054 1.05447281869397e-11 30 0 0 23 5310 WP2855 Dopaminergic Neurogenesis 1.00000000001054 1.05447281869397e-11 30 0 0 23 5310 WP3844 PI3K-AKT-mTOR signaling pathway and therapeutic opportunities 1.00000000001054 1.05447281869397e-11 30 0 0 23 5310 WP98 Prostaglandin Synthesis and Regulation 1.00000000001054 1.05447281869397e-11 30 0 0 23 5310 WP2586 Aryl Hydrocarbon Receptor 1.00000000001087 1.08651680692696e-11 48 0 0 23 5310 WP2873 Aryl Hydrocarbon Receptor Pathway 1.00000000001087 1.08651680692696e-11 48 0 0 23 5310 WP2848 Differentiation Pathway 1.00000000001087 1.08651680692696e-11 48 0 0 23 5310 WP2849 Hematopoietic Stem Cell Differentiation 1.00000000001087 1.08651680692696e-11 48 0 0 23 5310 WP1982 Sterol Regulatory Element-Binding Proteins (SREBP) signalling 1.00000000001106 1.10562224033188e-11 73 0 0 23 5310 WP1530 miRNA Regulation of DNA Damage Response 1.00000000001106 1.10583393972798e-11 93 0 0 23 5310 WP2355 Corticotropin-releasing hormone signaling pathway 1.00000000001106 1.10583393972798e-11 93 0 0 23 5310 WP69 T-Cell antigen Receptor (TCR) Signaling Pathway 1.00000000001123 1.12324602097308e-11 91 0 0 23 5310 WP3925 Amino Acid metabolism 1.00000000001123 1.12324602097308e-11 91 0 0 23 5310 WP2884 NRF2 pathway 1.00000000001146 1.14617516184755e-11 143 0 0 23 5310 WP2865 IL1 and megakaryocytes in obesity 1.00000000001169 1.16869292501773e-11 25 0 0 23 5310 WP1528 Physiological and Pathological Hypertrophy of the Heart 1.00000000001169 1.16869292501773e-11 25 0 0 23 5310 WP3668 Hypothesized Pathways in Pathogenesis of Cardiovascular Disease 1.00000000001169 1.16869292501773e-11 25 0 0 23 5310 WP2895 Differentiation of white and brown adipocyte 1.00000000001169 1.16869292501773e-11 25 0 0 23 5310 WP205 IL-7 Signaling Pathway 1.00000000001169 1.16869292501773e-11 25 0 0 23 5310 WP560 TGF-beta Receptor Signaling 1.00000000001177 1.17653382236428e-11 58 0 0 23 5310 WP1984 Integrated Breast Cancer Pathway 1.00000000001185 1.18478683118132e-11 154 0 0 23 5310 WP694 Arylamine metabolism 1.00000000001187 1.18705732388417e-11 6 0 0 23 5310 WP1981 Thyroxine (Thyroid Hormone) Production 1.00000000001187 1.18705732388417e-11 6 0 0 23 5310 WP1600 Nicotine Metabolism 1.00000000001187 1.18705732388417e-11 6 0 0 23 5310 WP3891 Benzene metabolism 1.00000000001187 1.18705732388417e-11 6 0 0 23 5310 WP897 Androgen receptor signaling pathway 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP2889 Oxytocin signaling 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP3302 eIF5A regulation in response to inhibition of the nuclear export system 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP2491 Diclofenac Metabolic Pathway 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP3633 Caffeine and Theobromine metabolism 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP2253 Pilocytic astrocytoma 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP1133 Androgen receptor signaling pathway 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP521 Amino acid conjugation of benzoic acid 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP733 Serotonin Receptor 2 and STAT3 Signaling 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP1603 Nicotine Activity on Chromaffin Cells 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP1941 Peroxisomal beta-oxidation of tetracosanoyl-CoA 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP690 Polyol Pathway 1.00000000001192 1.19150471558073e-11 4 0 0 23 5310 WP1471 Target Of Rapamycin (TOR) Signaling 1.00000000001204 1.2039841205348e-11 37 0 0 23 5310 WP3614 Photodynamic therapy-induced HIF-1 survival signaling 1.00000000001204 1.2039841205348e-11 37 0 0 23 5310 WP619 Type II interferon signaling (IFNG) 1.00000000001204 1.2039841205348e-11 37 0 0 23 5310 WP3414 Initiation of transcription and translation elongation at the HIV-1 LTR 1.00000000001204 1.2039841205348e-11 37 0 0 23 5310 WP3529 Zinc homeostasis 1.00000000001204 1.2039841205348e-11 37 0 0 23 5310 WP2446 Retinoblastoma (RB) in Cancer 1.00000000001224 1.22379693496797e-11 88 0 0 23 5310 WP3627 Gut-Liver Indole Metabolism 1.00000000001281 1.28089717651991e-11 1 0 0 23 5310 WP188 Focal Adhesion 1.00000000001281 1.28089717651991e-11 1 0 0 23 5310 WP1 Statin Pathway 1.00000000001281 1.28089717651991e-11 1 0 0 23 5310 WP108 Selenium metabolism/Selenoproteins 1.00000000001281 1.28089717651991e-11 1 0 0 23 5310 WP3191 TSLP Signaling Pathway 1.00000000001281 1.28089717651991e-11 1 0 0 23 5310 WP2536 Colchicine Metabolic Pathway 1.00000000001281 1.28089717651991e-11 1 0 0 23 5310 WP661 Glucose Homeostasis 1.00000000001281 1.28089717651991e-11 1 0 0 23 5310 WP2190 One carbon donor 1.00000000001281 1.28089717651991e-11 1 0 0 23 5310 WP3670 Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway 1.00000000001297 1.29670768318842e-11 21 0 0 23 5310 WP2533 Glycerophospholipid Biosynthetic Pathway 1.00000000001297 1.29670768318842e-11 21 0 0 23 5310 WP691 Tamoxifen metabolism 1.00000000001297 1.29670768318842e-11 21 0 0 23 5310 WP2507 Nanomaterial induced apoptosis 1.00000000001297 1.29670768318842e-11 21 0 0 23 5310 WP24 Peptide GPCRs 1.00000000001322 1.32200258812321e-11 74 0 0 23 5310 WP2572 Primary Focal Segmental Glomerulosclerosis FSGS 1.00000000001322 1.32200258812321e-11 74 0 0 23 5310 WP3303 Rac1/Pak1/p38/MMP-2 pathway 1.00000000001324 1.32367517843975e-11 68 0 0 23 5310 WP45 G1 to S cell cycle control 1.00000000001324 1.32367517843975e-11 68 0 0 23 5310 WP465 Tryptophan metabolism 1.00000000001324 1.32387446992641e-11 46 0 0 23 5310 WP1591 Heart Development 1.00000000001324 1.32387446992641e-11 46 0 0 23 5310 WP3878 ATM Signaling Network in Development and Disease 1.00000000001324 1.32387446992641e-11 46 0 0 23 5310 WP1971 Integrated Cancer Pathway 1.00000000001324 1.32387446992641e-11 46 0 0 23 5310 WP268 Notch Signaling Pathway 1.00000000001324 1.32387446992641e-11 46 0 0 23 5310 WP28 Selenium Metabolism and Selenoproteins 1.00000000001324 1.32387446992641e-11 46 0 0 23 5310 WP411 mRNA Processing 1.00000000001347 1.34749645554604e-11 132 0 0 23 5310 WP2203 Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway 1.00000000001357 1.3574434298789e-11 47 0 0 23 5310 WP534 Glycolysis and Gluconeogenesis 1.00000000001417 1.41737960781316e-11 49 0 0 23 5310 WP410 Diurnally Regulated Genes with Circadian Orthologs 1.00000000001417 1.41737960781316e-11 49 0 0 23 5310 WP286 IL-3 Signaling Pathway 1.00000000001417 1.41737960781316e-11 49 0 0 23 5310 WP51 Regulation of Actin Cytoskeleton 1.00000000001463 1.46347162478307e-11 149 0 0 23 5310 WP111 Electron Transport Chain 1.00000000001486 1.48630817949349e-11 92 0 0 23 5310 WP15 Selenium Micronutrient Network 1.00000000001663 1.66346594760416e-11 87 0 0 23 5310 WP437 EGF/EGFR Signaling Pathway 1.00000000001668 1.66772359408186e-11 162 0 0 23 5310 WP615 Senescence and Autophagy in Cancer 1.00000000001727 1.72745241094858e-11 106 0 0 23 5310 WP2513 Nanoparticle triggered regulated necrosis 1.00000000001764 1.76441044931456e-11 11 0 0 23 5310 WP80 Nucleotide GPCRs 1.00000000001764 1.76441044931456e-11 11 0 0 23 5310 WP1455 Serotonin Transporter Activity 1.00000000001764 1.76441044931456e-11 11 0 0 23 5310 WP2854 Gene regulatory network modelling somitogenesis 1.00000000001764 1.76441044931456e-11 11 0 0 23 5310 WP3630 NAD metabolism, sirtuins and aging 1.00000000001764 1.76441044931456e-11 11 0 0 23 5310 WP206 Fatty Acid Omega Oxidation 1.00000000002107 2.10719800094099e-11 15 0 0 23 5310 WP197 Cholesterol Biosynthesis 1.00000000002107 2.10719800094099e-11 15 0 0 23 5310 WP2435 Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis 1.00000000002107 2.10719800094099e-11 15 0 0 23 5310 WP3 Transcriptional activation by NRF2 1.00000000002107 2.10719800094099e-11 15 0 0 23 5310